Today! Join @RAPCancer and @DukeGUCancer @DukeCancer for a #prostatecancer Clinical Trials Learning Session: https://t.co/KLzVAqeBbg
News
Recent News +++
Bipolar Androgen Therapy for Patients Who Have Progressed on Abiraterone
Media Relations by PCCTC February 26, 2021Led by Dr. Samuel R. Denmeade and his team at Johns Hopkins School of Medicine – Sid...
Learn MoreCCC19 Registry Launched to Understand COVID-19 in Patients with Cancer
Media Relations by Hannah Slater via CancerNetwork March 27, 2020All are encouraged to participate to quickly gather details related to patients with cance...
Learn MoreDr. Dana Rathkopf Discusses IRONMAN Registry with UroToday
Media Relations by PCCTC February 12, 2020IRONMAN – An International Registry for Men with Advanced Prostate Cancer.
Learn MorePCCTC Investigators Author Key Paper on Liquid Biopsy Data
Media Relations by PCCTC February 4, 2020Effort organized by BloodPAC describes minimum technical data elements for liquid biopsy d...
Learn MoreProstate Cancer ABCs Presents Patient and Caregiver Conference
Media Relations by PCCTC January 23, 2020Free event featuring PCCTC advocates Jan Manarite and Joel Nowak will take place Saturday,...
Learn MorePhase I DSTP3086S Trial Results Published
Media Relations by PCCTC November 11, 2019PCCTC study demonstrates safety and antitumor activity of humanized immunoglobulin G1 anti...
Learn MoreAdvocacy Symposium Led by PCCTC Investigator
Media Relations by PCCTC August 10, 2018Dr. Elisabeth Heath of Karmanos Cancer Institute will head up the 8th Annual Prostate Canc...
Learn MoreBlood Test Predicts Treatment Response, Survival in Metastatic Disease
Media Relations by PCCTC June 29, 2018PCCTC Scientific Oversight Committee Chair, Howard I. Scher, MD leads international study....
Learn MoreThe PCCTC Is Expanding Its Trial Management Capabilities
Media Relations by PCCTC June 12, 2018To better meet the needs of our partners the PCCTC is expanding its infrastructure. Our ce...
Learn MoreEarly Development Led by the PCCTC, FDA Approval Now Sought for Apalutamide
Media Relations by Jason Harris - OncLive October 12, 2017A new drug application (NDA) has been submitted to the FDA for apalutamide (ARN-509) for t...
Learn MoreTeam PCCTC Joins Movember Effort
Media Relations by PCCTC November 1, 2016Prostate cancer is the second most common cancer in men worldwide. The PCCTC and Movember ...
Learn MoreFollow Us
Join @RAPCancer’s Dr @kdcmdphd and Drs @AarmstrongDuke and @Daniel_J_George on March 20 for a virtual session to le… https://t.co/RLS6DAEqgP
The intent of @IRONMANregistry is to establish an International Registry to Improve Outcomes in Men with Advanced P… https://t.co/75bBBFvZyO
Join our team of dedicated clinical research professionals! The Prostate Cancer Clinical Trials Consortium is currently seeking a Quality Manager and Clinical Data Manager to help fulfill our…
2018-23944 Clinical Data Manager, Prostate Cancer Clinical Trials Consortium (PCCTC) | Memorial Sloan Kettering Cancer Center Careers
careers.mskcc.org
Committed to world-class science!
Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.